人绒毛膜促性腺激素诱导的双调蛋白刺激人黄素化颗粒细胞中芳香化酶表达:黄体期雌二醇产生的一种机制
本研究为体外实验,探讨双调蛋白(AREG)是否调控人黄素化颗粒细胞(hGL)的芳香化酶表达与雌二醇(E2)生成。结果显示AREG经EGFR-AKT通路介导hCG诱导的芳香化酶上调和E2产生,卵泡液AREG蛋白水平与取卵后2天血清E2及卵泡液E2呈正相关。
要点
- AREG刺激hGL细胞芳香化酶表达和E2产生,经EGFR-AKT通路介导。
- 抑制EGFR活性或敲低AREG可减弱hCG诱导的芳香化酶上调和E2产生。
- 卵泡液AREG蛋白水平与取卵后2天血清E2及卵泡液E2呈正相关。
核心结论
- AREG介导hCG诱导的hGL细胞芳香化酶表达上调和E2产生。
- 结果首次提示hCG诱导的AREG参与月经周期黄体期芳香化酶表达和E2产生。
研究设计与样本
- 实验研究,为期1年,采用原代hGL细胞进行体外研究。
- hGL细胞来自接受IVF治疗的女性,卵泡液和血清来自65例不孕女性。
主要发现
- AREG处理刺激hGL细胞芳香化酶表达和E2产生。
- 药理学抑制剂和特异性siRNA显示AREG经EGFR介导的AKT信号通路激活刺激芳香化酶表达和E2产生。
- 抑制EGFR活性和敲低AREG减弱hCG诱导的芳香化酶表达上调和E2产生。
- 卵泡液AREG蛋白水平与取卵后2天血清E2水平及卵泡液E2水平呈正相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究的体外设置可能不能反映真实的卵巢内微环境。
- 临床数据来自小样本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does amphiregulin (AREG), the most abundant and important epidermal growth factor receptor (EGFR) ligand in the follicular fluid, regulate aromatase expression in human granulosa-lutein (hGL) cells? SUMMARY ANSWER: AREG mediates the hCG-induced up-regulation of aromatase expression and estradiol (E2) production in hGL cells. WHAT IS KNOWN ALREADY: AREG expression and secretion are rapidly induced by hCG in hGL cells and mediate physiological functions of LH/hCG in the ovary. EGFR protein is expressed in follicles not only in the pre-ovulatory phase but also throughout the luteal phase of the menstrual cycle. After the LH surge, the human corpus luteum secretes high levels of E2, which regulates various luteal cell functions. Aromatase is an enzyme responsible for a key step in the biosynthesis of E2. However, whether AREG regulates aromatase expression and E2 production in hGL cells remains unexplored. STUDY DESIGN, SIZE, DURATION: This study is an experimental study performed over a 1-year period. In vitro investigations examined the role of AREG in the regulation of aromatase expression and E2 production in primary hGL cells. PARTICIPANTS/MATERIALS, SETTING, METHODS: Primary hGL cells were obtained from women undergoing IVF treatment in an academic research center. Aromatase mRNA and protein levels were examined after exposure of hGL cells to recombinant human AREG, hCG or LH. The EGFR tyrosine kinase inhibitor AG1478, PI3K inhibitor LY294002 and siRNAs targeting EGFR, LH receptor, StAR and AREG were used to verify the specificity of the effects and to investigate the underlying molecular mechanisms. Reverse transcription quantitative real-time PCR (RT-qPCR) and western blot were used to measure the specific mRNA and protein levels, respectively. Follicular fluid and serum were collected from 65 infertile women during IVF treatment. Pearson's correlation analysis was performed to examine the correlation coefficient between two values. MAIN RESULTS AND THE ROLE OF CHANCE: Treatment of hGL cells with AREG-stimulated aromatase expression and E2 production. Using pharmacological inhibitors and specific siRNAs, we revealed that AREG-stimulated aromatase expression and E2 production via EGFR-mediated activation of the protein kinase B (AKT) signaling pathway. In addition, inhibition of EGFR activity and AREG knockdown attenuated hCG-induced up-regulation of aromatase expression and E2 production. Importantly, the protein levels of AREG in the follicular fluid were positively correlated with the E2 levels in serum after 2 days of oocyte pick-up and in the follicular fluid of IVF patients. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The in vitro setting of this study is a limitation that may not reflect the real intra-ovarian microenvironment. Clinical data were obtained from a small sample size. WIDER IMPLICATIONS OF THE FINDINGS: Our results provide the first evidence that hCG-induced AREG contributes to aromatase expression and E2 production in the luteal phase of the menstrual cycle. A better understanding of the hormonal regulation of female reproductive function may help to develop new strategies for the treatment of clinical infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China for Young Scientists (81601253), the specific fund of clinical medical research of Chinese Medical Association (16020160632) and the Foundation from the First Affiliated Hospital of Zhengzhou University for Young Scientists to Lanlan Fang. This work was also supported by an operating grant from the National Natural Science Foundation of China (81820108016) to Ying-Pu Sun. All authors declare no conflict of interest.
引用
- Fang L, Yu Y, Li Y, et al. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase. Hum Reprod. 2019. PMID: 31553790. doi:10.1093/humrep/dez171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。